Gryska David W
SEC-identified person · CIK 1202335 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Mind Medicine (Mindmed) Inc. MNMD | Director | filed 2023–2026 |
| Tocagen Inc TOCA | Director | filed 2023–2026 |
| Seagen Inc. SGEN | Director | filed 2006–2023 |
| Aerie Pharmaceuticals INC AERI | Director | filed 2013–2022 |
| GW Pharmaceuticals PLC GWPH | Director | filed 2020–2021 |
| Protein Design Labs INC/DE pdli | Director | filed 2014–2020 |
| Incyte Corp INCY | Executive Vice President, CFO | filed 2014–2018 |
| Argos Therapeutics INC ARGS | Director | filed 2014–2014 |
| Hyperion Therapeutics INC HPTX | Director | filed 2012–2013 |
| Myriad Pharmaceuticals, Inc. myrx | Director · Chief Operating Officer | filed 2012–2012 |
| Celgene Corp /DE/ CELG | Chief Financial Officer | filed 2006–2010 |
| Cotherix INC CTRX | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.